Ruxolitinib for Acute Graft-versus-Host Disease. Reply
N Engl J Med
.
2020 Jul 30;383(5):10.1056/NEJMc2020763#sa3.
doi: 10.1056/NEJMc2020763.
Authors
Robert Zeiser
1
,
Nikolas von Bubnoff
2
,
Gérard Socié
3
Affiliations
1
University of Freiburg, Freiburg, Germany robert.zeiser@uniklinik-freiburg.de.
2
University Hospital Schleswig-Holstein, Lübeck, Germany.
3
Hôpital St. Louis, Paris, France.
PMID:
32726542
DOI:
10.1056/NEJMc2020763
No abstract available
Publication types
Letter
Comment
MeSH terms
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Humans
Nitriles
Pyrazoles
Pyrimidines
Substances
Nitriles
Pyrazoles
Pyrimidines
ruxolitinib